21-45488441-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001379500.1(COL18A1):​c.1920T>C​(p.Leu640Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 1,613,522 control chromosomes in the GnomAD database, including 76,375 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L640L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.32 ( 7874 hom., cov: 32)
Exomes 𝑓: 0.30 ( 68501 hom. )

Consequence

COL18A1
NM_001379500.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0120

Publications

44 publications found
Variant links:
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL18A1 Gene-Disease associations (from GenCC):
  • Knobloch syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Knobloch syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet
  • hereditary glaucoma, primary closed-angle
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 21-45488441-T-C is Benign according to our data. Variant chr21-45488441-T-C is described in ClinVar as [Benign]. Clinvar id is 261895.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.012 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.361 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL18A1NM_001379500.1 linkc.1920T>C p.Leu640Leu synonymous_variant Exon 18 of 42 ENST00000651438.1 NP_001366429.1
COL18A1NM_130444.3 linkc.3165T>C p.Leu1055Leu synonymous_variant Exon 17 of 41 NP_569711.2 P39060
COL18A1NM_030582.4 linkc.2460T>C p.Leu820Leu synonymous_variant Exon 17 of 41 NP_085059.2 P39060D3DSM5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL18A1ENST00000651438.1 linkc.1920T>C p.Leu640Leu synonymous_variant Exon 18 of 42 NM_001379500.1 ENSP00000498485.1 P39060-2
COL18A1ENST00000355480.10 linkc.2460T>C p.Leu820Leu synonymous_variant Exon 17 of 41 1 ENSP00000347665.5 P39060-1
COL18A1ENST00000359759.8 linkc.3165T>C p.Leu1055Leu synonymous_variant Exon 17 of 41 5 ENSP00000352798.4 P39060-3

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
48675
AN:
151910
Hom.:
7863
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.366
Gnomad AMI
AF:
0.204
Gnomad AMR
AF:
0.292
Gnomad ASJ
AF:
0.320
Gnomad EAS
AF:
0.243
Gnomad SAS
AF:
0.334
Gnomad FIN
AF:
0.356
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.300
Gnomad OTH
AF:
0.324
GnomAD2 exomes
AF:
0.303
AC:
75475
AN:
249126
AF XY:
0.304
show subpopulations
Gnomad AFR exome
AF:
0.373
Gnomad AMR exome
AF:
0.254
Gnomad ASJ exome
AF:
0.333
Gnomad EAS exome
AF:
0.241
Gnomad FIN exome
AF:
0.343
Gnomad NFE exome
AF:
0.303
Gnomad OTH exome
AF:
0.295
GnomAD4 exome
AF:
0.305
AC:
445715
AN:
1461494
Hom.:
68501
Cov.:
49
AF XY:
0.305
AC XY:
221950
AN XY:
727022
show subpopulations
African (AFR)
AF:
0.374
AC:
12526
AN:
33480
American (AMR)
AF:
0.261
AC:
11685
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
8817
AN:
26134
East Asian (EAS)
AF:
0.257
AC:
10216
AN:
39696
South Asian (SAS)
AF:
0.322
AC:
27813
AN:
86258
European-Finnish (FIN)
AF:
0.329
AC:
17477
AN:
53144
Middle Eastern (MID)
AF:
0.321
AC:
1852
AN:
5768
European-Non Finnish (NFE)
AF:
0.303
AC:
337438
AN:
1111918
Other (OTH)
AF:
0.296
AC:
17891
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
19152
38303
57455
76606
95758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11158
22316
33474
44632
55790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.320
AC:
48714
AN:
152028
Hom.:
7874
Cov.:
32
AF XY:
0.324
AC XY:
24095
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.366
AC:
15183
AN:
41476
American (AMR)
AF:
0.292
AC:
4461
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.320
AC:
1108
AN:
3466
East Asian (EAS)
AF:
0.244
AC:
1252
AN:
5134
South Asian (SAS)
AF:
0.334
AC:
1610
AN:
4818
European-Finnish (FIN)
AF:
0.356
AC:
3759
AN:
10572
Middle Eastern (MID)
AF:
0.313
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
0.300
AC:
20385
AN:
67960
Other (OTH)
AF:
0.322
AC:
679
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1696
3392
5089
6785
8481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.305
Hom.:
27466
Bravo
AF:
0.317
Asia WGS
AF:
0.290
AC:
1011
AN:
3478
EpiCase
AF:
0.305
EpiControl
AF:
0.308

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Knobloch syndrome Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 23, 2017
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary glaucoma, primary closed-angle Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.4
DANN
Benign
0.50
PhyloP100
-0.012
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11702425; hg19: chr21-46908355; COSMIC: COSV60587987; COSMIC: COSV60587987; API